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Leukotriene B, (LTB,) has been reported to promote the formation of lung oedema when infused into the 
pulmonary circulation of adult animals. The present study evaluated the hypothesis that LTB, was 
responsible, in part, for the oedema that develops during oxidative injury of the immature lung. Significant 
increases were found in LTB, concentration in bronchoalveolar lavage fluid obtained from pre-term guinea 
pig pups maintained in 95% oxygen for 48 h (PcO.05) and 72 h (PcO.05) compared to pups maintained in 21% 
oxygen. Cellular analysis of lavage fluid revealed a concurrent influx of neutrophils into the hyperoxic-injured 
lung at these times. The protein concentration of lavage fluid was also increased by 48-h hyperoxia exposure 
indicating elevated pulmonary microvascular permeability. 
In a second series of experiments, pups exposed to 95% oxygen (and 21% oxygen controls) were treated with 
a specific LTB, antagonist (U-75302) at either 0.5, 1.5 or 3.0 mg 100 g body wt to ascertain if LTB, played a 
role in either neutrophil recruitment or oedema formation in the immature lung. The number of neutrophils 
recovered in bronchoalveolar lavage fluid was significantly reduced, compared to vehicle-treated pups, in pups 
treated with U-75302, at both 1.5 and 3.0 mg/lOO g body wt but not 0.5 mg/lOO g body wt. Histopathological 
analysis of pups treated with 1.5 mg U-75302/100 g body wt revealed fewer neutrophils in the pulmonary 
interstitium (198 vs. 218 mm-‘, PcO.05). The extent of lung microvascular permeability, elevated by 
hyperoxic exposure, was modulated by increasing concentrations of U-75302. Specifically, treatment with 0.5, 
1.5 and 3.0 mg U-75302/100 g body wt reduced microvascular permeability by 17, 67 and 98%, respectively. In 
conclusion, LTB, plays an important role in oedema formation in acute oxidative injury of the immature lung 
and this is mediated, in part, through neutrophils. 
Introduction 
With improved survival of extremely premature 
infants, respiratory disorders in pre-term babies have 
become one of the major problems facing neonatolo- 
gists (1). Clinically, two of the main features of both 
acute and chronic respiratory disease in infants are 
pulmonary inflammation (2) and oedema (3) and 
both correlate with the known action of Leukotriene 
B, (LTB,) (5S, 12R-dihydroxy-6, 14-cis-8, lo- 
transeicosatetraenoic acid), a potent metabolite of 
arachidonate (4,5). Indeed, increased concentrations 
of this eicosanoid have been observed in broncho- 
alveolar lavage (BAL) fluid obtained from infants 
with chronic lung disease (CLD) (6). As the patho- 
genesis of both respiratory distress syndrome (RDS) 
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and CLD have proved complex and difficult to 
manage, the control of pulmonary inflammation and 
oedema may represent useful therapeutic approaches. 
It has previously been established that the pulmo- 
nary sequelae in the pre-term guinea pig following 
exposure to oxygen are similar to those seen in the 
human infant with RDS (7) and CLD (8). The main 
findings are pulmonary inflammation, particularly 
neutrophil infiltration of the lung, and increased 
microvascular permeability. Histological examina- 
tion of the lungs of pre-term animals with respiratory 
distress has confirmed the presence of acute lung 
injury and hyaline membranes (7). 
As part of ongoing studies of respiratory disorders 
of pre-term infants, this paper reports an investiga- 
tion of the role of LTB, in acute oxidative lung injury 
of the pre-term guinea pig. Specifically, it was exam- 
ined whether exposure to elevated concentrations of 
oxygen leads to an accumulation of LTB, in the 
alveoli of pre-term animals. Having established that 
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this was indeed the case, a specific LTB, antagonist 
(U-75302) was employed to determine whether 
interruption of the LTB, signalling pathway influ- 
enced either neutrophil accumulation or oedema 
formation in the immature lung. 
Materials and Methods 
All chemicals were obtained from Sigma Chemicals 
Co. (Poole, Dorset, U.K.) unless otherwise stated. 
EXPERIMENTAL PROTOCOL 
The pre-term guinea pig model has been described 
in detail previously (7). Briefly, guinea pig pups were 
delivered by caesarean section after 65 days gestation 
(full term is 68 days) and were immediately revived 
and dried gently in a stream of warm air. Up to five 
pre-term pups and a lactating surrogate female were 
housed in 25-1 sealed Perspex cages supplied with dry 
gas mixtures. Pre-term pups were randomly allocated 
to receive either 21% or 95% oxygen for up to 72 h. In 
the first study, animals (6-8 pups group- ‘) were 
anaesthetized after 24, 48 or 72 h and a BAL carried 
out as described below. Inflammatory cell influx, 
microvascular permeability and LTB, concentration 
were determined by examining the lavage fluid. In a 
second study, 3-day-old pre-term pups exposed to 
either 21% or 95% oxygen were randomly allocated 
to receive the LTB, antagonist (U-75302) or vehicle 
(5% ethanol; 1% Tween 80) at a dose of either 0.5, 1.5 
or 3.0 mg/lOO g body wt every 12 h over a 72-h 
period. At the end of this time, the animals were 
anaesthetized and BAL was performed (5-6 pups 
group - ‘). In addition, in a further series of experi- 
ments in which pups received 1.5 mg U-753021 
100 g body wt for 72 h, the lungs of the animals were 
perfused with fixative for histochemical analysis 
(2-3 pups group - ‘). 
BRONCHOALVEOLAR LAVAGE 
Guinea pig pups were anaesthetized by intra- 
peritoneal injection of pentobarbital (50 mg kg- ‘). 
After exposure of the trachea, a tracheotomy was 
performed and a 14-gauge cannula inserted and 
secured. The animals were then exsanguinated by 
abdominal aortic section and the pulmonary circula- 
tion perfused with 5 ml of saline at 37°C. The lungs 
were lavaged in situ with five 2-ml aliquots of sterile 
saline (37°C). The lavage cells were then placed by 
centrifugation at 200 g for 10 min at 4°C. Superna- 
tant (0.5 ml) was frozen at - 70°C for subsequent 
analysis of total protein as an index of microvascular 
permeability, while the remainder of the lavage fluid 
was used for the determination of the concentration 
of LTB,. 
TOTAL AND DIFFERENTIAL LEUKOCYTE COUNTS 
A total nucleated cell count in the BAL was 
performed using a Neubauer haemocytometer. 
Cytospin preparations were stained with May- 
Grunwald-Giemsa and differential cell counts per- 
formed on 300 cells. Results are expressed as the 
total number of cells per ml of lavage fluid recovered 
from each animal. No correction was made for the 
volume of lavage fluid recovered as this was uni- 
formly 85-90% of the original volume used. Total 
and differential leukocyte counts were performed 
on blood taken by cardiac puncture prior to 
exsanguination. 
ASSESSMENT OF MICROVASCULAR PERMEABILITY 
Changes in vascular permeability were quantified 
by determining the protein content of the lavage fluid 
since it has previously been shown that approxi- 
mately 50% of the total protein recovered in BAL 
from oxygen-exposed guinea pigs is plasma albumin 
(7). Total protein was measured in unconcentrated 
lavage fluid using the bicinchoninic acid assay (9). 
Absorbance was measured at 562 nm with a 
Dynatech MR 580 reader using bovine serum albu- 
min standard. Results are expressed as mg of protein 
per ml of lavage fluid recovered. 
EXTRACTION OF LTB, 
Leukotrienes were extracted from BAL fluid 
and purified as described by Taniguchi et al. (10). 
Bronchoalveolar lavage samples were immediately 
combined with two volumes of ethanol and kept on 
ice for up to 2 h. Water was then added to give a final 
concentration of 10% ethanol. The mixture was 
centrifuged at 450 g for 10 min. The acidified super- 
natant (pH 3.0) was then passed through an octa- 
decylsilyl (ODS) silica cartridge, which was 
subsequently washed with 10% aqueous ethanol 
(15 ml), water (15 ml), petroleum ether (15 ml) and 
methylformate (10 ml). The final fraction was dried 
under nitrogen and the residue dissolved in 0.5 ml of 
radioimmunoassay (RIA) buffer (50 mM TRIS at 
pH 8.6 containing 0.1% gelatin). With this approach, 
recovery of added [3H]LTB, was greater than 90%. 
ASSAY OF LTB, 
Leukotriene B, concentration in BAL fluid was 
measured in duplicate by radioimmunoassay (RIA) 
with antiserum selective for LTB,. Aliquots (0.1 ml) 
of extracted BAL samples were placed in disposable 
glass tubes and [3H]LTB, in RIA buffer (0.1 ml 
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containing approximately 4000 dpm) was added to 
give a total incubation volume of 0.4 ml. The mixture 
was incubated at 4°C for 18 h. Free LTB, was 
adsorbed onto dextran-coated charcoal and after 
centrifugation at 2000 g for 15 min, the supernatant 
containing the antibody-bound LTB, was decanted 
into scintillation vials. Following the addition of 
scintillant, radioactivity was determined in a scintil- 
lation counter. Cross-reactivity of the LTB, antibody 
with 15-hydroxyeicosatetraenoic acid (HETE), 
di-HETE and thromboxane B, was less than 1%. 
Coefficient of variation was 8.9%. 
HISTOPATHOLOGICAL ANALYSIS 
The pulmonary histological sequelae of exposure 
to 95% 0, in the presence or absence of U-75302 was 
assessed at 72 h. Animals were anaesthetized, the 
trachea cannulated and the pulmonary circulation 
flushed as described above. The lungs were inflated 
with air at a constant pressure of 10 cm H,O and 
were simultaneously perfused via the right ventricle 
for 60 min with half-strength Karnovsky’s fixative. 
The heart-lung preparation was then dissected 
from the thorax and immersed in full-strength 
Karnovsky’s fixative (2.5% glutaraldehyde and 2.5% 
paraformaldehyde) for 2448 h. 
For light microscopy, 4ym sections were stained 
with haematoxylin, and eosin and with Martius 
Scarlet Blue. The percentage airspace was determined 
by point counting from the section stained with 
Martius Scarlet Blue using an eyepiece graticule 
providing a grid with 122 points. A minimum of 600 
points (five-six low-power fields) were examined for 
each section. Using the 100 x oil-immersion objec- 
tive, the number of neutrophils in 30 random high- 
power fields was determined. The total granulocyte 
count was then adjusted for the percentage airspace 
to give the number of neutrophils per mm* of 
tissue. 
STATISTICAL ANALYSIS 
The results are presented as means and standard 
deviations. The significance of differences between 
survival curves was assessed using the log rank test. 
The remaining data was analysed using a two-way 
analysis of variance (ANOVA). The unpaired Stu- 
dent’s t-test was used when ANOVA indicated a 
within-group statistical significance. 
Results 
No difference was observed in the survival of 
pre-term pups maintained in 21% oxygen (six of 
seven pups) or 95% oxygen (seven of eight pups) for 
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Fig. I Leukotriene B,, neutrophil and microvascular per- 
meability changes in the lungs of pre-term guinea pigs 
exposed to 21% (open bars) or 95% oxygen (closed bars) for 
72 h. Mean values with each bar representing the standard 
deviation for between six and eight animals per group. 
*P<O.O5; ‘yPcO.01; 21% vs. 95% oxygen. 
a 72-h period. Both fatalities were within 12 h of 
birth when the pups were in severe respiratory dis- 
tress. Exposure to 95% oxygen increased the number 
of circulating inflammatory cells by 72 h. This was 
due mainly to an increase in the number of neu- 
trophils (9.5 vs. 3.4*105 ml ~ ‘, WO.05). Pulmonary 
microvascular permeability was significantly in- 
creased following 48 h in hyperoxic-exposed pups 
(PcO.05) as was the number of neutrophils recovered 
in BAL fluid (WO.05; Fig. 1). These indices of lung 
injury were accompanied by a six-fold increase in the 
concentration of LTB, in BAL fluid (Fig. 1). Expo- 
sure to hyperoxia for a further 24 h did not result 
in any further increase in LTB, concentration, 
neutrophil numbers or microvascular permeability. 
A second series of experiments was carried out to 
examine the effect of a LTB, antagonist, U-75302. In 
these experiments, in which three different concen- 
trations of U-75302 were administered, three of 19 
animals maintained in 21% oxygen died during 
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Table I Neutrophil and eosinophil numbers and protein concentration in bronchoalveolar 
lavage fluid (BALF) from pre-term guinea pig pups exposed to 21% and 95% oxygen in the 
presence of varying concentrations of U-75302 
U-75302 
@WOO g 
body wt) 
Oxygen 
(“/I 
Neutrophils 
(10 4 ml-’ BALF) 
Eosinophils 
( lo6 ml - ’ BALF) 
Protein 
(mg ml - ’ BALF) 
Vehicle 21 
Vehicle 95 
0.5 21 
0.5 95 
1.5 21 
1.5 9s 
3.0 21 
3.0 95 
1.03 f 0.61 
6.21 zk 1.84* 
0.82 f 0.58 
4.86 f 1.78* 
1.52 f 1.17 
1.93 f 1.87? 
1.45 zk 1.56 
1.85 f 0.79t 
0.32 rt 0.26 
0.45 f 0.31 
0.76 f 0.57 
0.67 f 0.45 
0.84 f 0.28 
0.79 f 0.37 
0.94 zk 0.31t 
0.88 + 0.37 
0.23 f 0.03 
0.63 + 0.1 l* 
0.17 f 0.08 
0.53 f 0.09* 
0.22 lir 0.06 
0.36 f 0.107 
0.27 f 0.08 
0.28 f 0.127 
*Different from 21% O,, P<O.OOS; values given as mean f SD. 
tDifferent from equivalent vehicle control, PcO.05. 
treatment with U-75302, while one of six pups died in 
21% oxygen during vehicle treatment. All fatalities 
again occurred within 12 h of delivery while the pups 
were still in respiratory distress. Of the 22 pups 
exposed to 95% oxygen and treated with U-75302, 19 
survived, as did all pups (six of six) maintained in 
95% oxygen and treated with vehicle. 
Treatment with U-75302 at the two highest doses 
(1.5 and 3.0 mg/lOO g body wt) resulted in significant 
increases in the number of circulating eosinophils 
(P<O.O05) and basophils (P<O.OS) compared to 
vehicle-treated animals. There was no effect of 
U-75302 on the number of circulating neutrophils at 
any dose considered (data not shown). 
Exposure to 95% oxygen resulted in a significant 
increase (PcO.01) in the number of neutrophils 
recovered in the BAL fluid (Table 1). Treatment with 
the lowest dose of U-75302 considered (0.5 mg/ 
100 g body wt) partially reduced (22%) neutrophil 
recruitment to the immature lung, while the two 
higher doses of 1.5 and 3.0 mg/lOO g body wt nearly 
completely blunted the response (Table 1). At the 
only dose considered histochemically (1.5 mg/ 
100 g body wt), U-75302 was seen to significantly 
reduce neutrophil recruitment by 18% to the lung 
parenchyma (PcO.05; Table 2, Plate 1). Treatment 
with U-75302 was always associated with higher 
numbers of eosinophils in lavage fluid, although this 
was only significant at the 3.0 mg/lOO g body wt dose, 
21% oxygen-treated pups (Table 2). 
As observed previously, exposure to 95% oxygen 
resulted in a significant increase in the protein con- 
centration in BAL fluid of vehicle-treated animals 
compared to those maintained in 21% oxygen. Treat- 
ment with U-75302 was found to reduce the extent 
Table 2 Percentage airspace and numbers of neutrophils in 
lung sections from pre-term guinea pig pups exposed to 21% 
and 95% oxygen in the presence of U-75302 or vehicle 
Treatment 
Oxygen 
(%I 
Airspace 
(“4 
Neutrophils 
(No mm - *) 
Vehicle 21 42.3 f 7.6 11o*t66 
Vehicle 95 35.5 lk 4.7 218 i 12.7* 
U-75302 21 43.5 f 3.5 108 f 8.5 
U-75302 95 37.0 f 6.0 198 f 10.9t 
*Different from 21% 02, control or U-75302, P<O,Ol; 
values given as mean f SD. 
tDifferent from 95% O,, control, P<O.O5. 
of lung permeability in a concentration-related 
manner (Table 1). So much so, that pups treated 
with 3.0 mg U-753021100 g body wt exhibited little 
increase in lung permeability at the end of 72 h in 
95% oxygen. 
Discussion 
Neutrophils are present in large numbers in the 
lungs of infants who receive supplemental oxygen 
(11). Indeed, infants who subsequently develop CLD 
have persistently elevated neutrophil counts. Since 
activated neutrophils can generate oxygen radicals, 
release an array of proteolytic enzymes and generate 
arachidonate products (12), it has been proposed that 
they exacerbate the microvascular permeability and 
oedema associated with hyperoxia-induced lung 
injury (13-15). To help elucidate the role of these 
immune cells in respiratory disease of pre-term 
neonates, an animal model of prematurity using the 
guinea pig has been developed (7). 
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Maintenance of pre-term guinea pigs in a hyper- 
oxic environment results in increased pulmonary 
microvascular permeability and oedema. Pulmonary 
oedema, an early event in this model occurring 
between 2448 h, develops due to the disruption of 
the endothelial cell layer which allows protein-rich 
fluid to leak at an increased rate from the micro- 
circulation into the pulmonary interstitium (7). Then, 
as the integrity of the epithelial cell layer is also 
compromised with Type 1 cell injury and less selec- 
tive tight junctions, the proteinaceous fluid enters the 
alveoli and interferes with surfactant function and 
respiratory gas exchanges (16). 
At present it is not clear what role, if any, neu- 
trophil infiltration to the immature lung contributes 
to the increase in microvascular permeability. If, as 
suggested by some investigators, neutrophils are 
responsible for much of the lung injury seen follow- 
ing hyperoxic-exposure (13-l 5) then downregulating 
or preventing this immune response may represent a 
useful therapeutic approach. The goal of this study 
was to determine if LTB,, a potent chemoattractant 
for neutrophils, was involved in their recruitment 
to the hyperoxia-injured lung and to examine the 
benefit of blocking the action of LTB, with a specific 
antagonist, U-75302. 
The potential importance of LTB, as a neutrophil 
chemoattractant in the immature lung was confirmed 
in the first series of experiments in which 72 h of 
hyperoxic exposure resulted in a four-fold increase 
in microvascular permeability. This response was 
accompanied by a six-fold increase in the concentra- 
tion of LTB, in BAL fluid, which in turn coincided 
with an accumulation of neutrophils in the pul- 
monary parenchyma and alveoli. Increased concen- 
trations of LTB, in BAL fluid have been reported for 
infants with CLD who also have oedematous and 
inflammatory cell responses (6). 
Leukotriene B, is a potent metabolite of arachido- 
nate formed by the lipoxygenase pathway (17), and 
increased concentrations have been reported in 
several animal models of lung injury (10,18,19). 
Taniguchi et al. (10) reported elevated levels of LTB, 
in BAL fluid from adult rats exposed to 95% oxygen 
for 66 h, the increase correlating with the influx of 
neutrophils to the lung. Indeed, it is now widely 
accepted that LTB, is a potent chemotactic agent for 
attracting neutrophils to the lung (520) and causing 
their adherence to endothelial surfaces (21). The 
source of the LTB, was not investigated in the 
present study, although possible sources include 
damaged endothelial cells, Type 1 epithelial or 
inflammatory cells (22,23). 
The second aim of the study was to determine what 
role LTB, plays in pulmonary inflammation and 
oedema formation. It has been demonstrated that 
hyperoxia primes cultured bovine pulmonary artery 
cells to release more prostaglandin (PGI,) and LTB, 
when stimulated with calcium ionophores (24). 
Administration of exogenous LTB, to hyperoxia- 
exposed rats results in increased PGI, formation and 
increased capillary permeability compared to nor- 
moxie controls and it has been suggested that hyper- 
oxic exposure primes lung tissue and capillaries to 
become more susceptible to the effects of LTB,. 
In the late 1980s it was shown that inhibition of 
leukotriene synthesis with diethylcarbamazine or 
antagonism of the sulfidopeptide leukotriene receptor 
with FPL 57231 prevented the acute pulmonary 
effects of endotoxin in cats (25), and also prevented 
death from an otherwise lethal dose of endotoxin 
in mice (18). In the present study, a structural ana- 
logue of LTB, (U-75302, 6-(6-(3-hydroxy-lE,5Z- 
undecadien-1-yl)-2-pyridinyl)-1, 5-hexanediol) was 
used which competitively inhibits the binding of 
[3H]LTB, to receptors on human neutrophils (26) 
and is a selective antagonist of the myotropic activity 
of LTB, on isolated lung parenchymal strips from 
guinea pig (27). It was speculated that administration 
of this compound to pre-term guinea pigs, exposed 
to supplemental oxygen, would reduce or prevent 
the increase in microvascular permeability and the 
accumulation of neutrophils in the lung. 
Accumulation of neutrophils into alveoli spaces 
was reduced dramatically after treatment with 
U-75302 at a dose of 1.5 mg/lOO g body wt and this 
also occurred to a lesser extent in lung parenchyma, 
suggesting that LTB, is acting as a chemotactic 
factor for neutrophils in the immature lung. These 
results differ in this respect from those obtained by 
Richards et al. (28) who used U-75302 in a guinea pig 
model of antigen-induced bronchopulmonary eosi- 
nophilia. These workers found that the neutrophilia 
associated with their model was not prevented by 
treatment with U-75302. They did, however, find that 
the influx of eosinophils to the lung was reduced, 
something that was not observed in the oxygen- 
injury, pre-term model. Indeed, an increase in eosi- 
nophil influx was recorded in all pups treated 
with U-75302. These differences may have arisen due 
to the different route of treatment employed (intra- 
peritoneal vs. oral), age of the guinea pigs used 
(pre-term vs. adult), or imposed stress (oxygen VS. 
albumin) utilized in the two studies. 
The most important finding of the present 
study was that U-75302 prevented the increase in 
pulmonary microvascular permeability normally 
associated with exposure to an elevated concentra- 
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tion of oxygen. Since the accumulation of neutrophils 
in the lung interstitium was only partially reduced in 
these animals, it is concluded that these cells are 
probably not solely responsible for the increased 
microvascular permeability seen in hyperoxia- 
exposed pups. However, it is conceivable that inter- 
ruption of the LTB, signalling pathway prevented the 
activation of neutrophils recruited to the lung and 
thus may have indirectly prevented the increase in 
microvascular permeability. Irrespective of the pre- 
cise mechanism involved, administration of an LTB, 
antagonist resulted in reduced microvascular per- 
meability and oedematous injury of the immature 
lung. 
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